Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Sierra Oncology Raises $135M Via Equity To Fund Lead Program Development

Sierra Oncology Inc (NASDAQ: SRRA) has priced its underwritten public offering of 4.07 million shares at $27 per share and the pre-funded warrants at $26.999 per pre-funded warrant.

See more from Benzinga

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.